Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Retrospective review of baseline practices prior to implementing an enhanced recovery programme.

Cardiology in the young·2026
Same author

Alterations in Metabolites Associated With Umbilical Cord Blood in Monozygotic Twins Discordant for Congenital Heart Disease.

Pediatric discovery·2026
Same author

Should delayed umbilical cord clamping at birth be practised in monochorionic twin pregnancies?

Archives of disease in childhood. Fetal and neonatal edition·2026
Same author

Pulmonary Atresia With Major Aorto-Pulmonary Collateral Arteries (MAPCAs): Timing and Type of Intervention.

Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual·2026
Same author

Anatomic Versus Physiologic Repair in Congenitally Corrected Transposition: A Propensity-Matched European Multicentre Study.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Atomic-resolution imaging of gold species at organic liquid-solid interfaces.

Science (New York, N.Y.)·2026

相关实验视频

Updated: Jun 21, 2026

Left Atrial Ligation in the Avian Embryo as a Model for Altered Hemodynamic Loading During Early Vascular Development
04:37

Left Atrial Ligation in the Avian Embryo as a Model for Altered Hemodynamic Loading During Early Vascular Development

Published on: June 16, 2023

缺血性左心综合征是什么意思

David J Barron1, Mark D Kilby, Ben Davies

  • 1Department of Cardiac Surgery, Birmingham Children's Hospital, Birmingham, UK. david.barron@bch.nhs.uk

Lancet (London, England)
|August 18, 2009
PubMed
概括

缺血性左心综合征 (HLHS) 管理已经从致命发展到通过手术干预可以治疗. 目前的策略包括分阶段的手术,新生儿移植和混合技术,为受影响的儿童提供更好的结果.

科学领域:

  • 儿童心脏病学 儿童心脏病学
  • 遗传性心脏缺陷 遗传性心脏缺陷
  • 新生儿心脏手术 新生儿心脏手术

背景情况:

  • 低发性左心综合征 (HLHS) 是一种严重的先天性心脏缺陷,其特点是左心部发育不良.
  • 从历史上看,HLHS的预后几乎是致命的,需要医疗和外科护理的进步.
  • 由于HLHS的复杂性,需要从出生到成年期进行专业的多学科管理.

研究的目的:

  • 审查目前对低可塑性左心综合征的外科治疗策略.
  • 讨论不断发展的治疗选择,包括分阶段缓解,移植和混合方法.
  • 突出管理HLHS患者进入青春期和成年期的持续挑战.

主要方法:

  • 对HLHS的手术技术的审查,重点是使用右心室进行分阶段的息.
  • 讨论替代治疗方案,如新生儿心脏移植.
  • 探索结合手术和干预方法的创新混合程序.

主要成果:

  • 手术干预显著提高了HLHS的生存率,改变了其以前致命的前景.
  • 阶段性程序,右心室支持两个循环,是当前管理的基石.
  • 新生儿移植和混合技术提供了替代或辅助的治疗途径.

更多相关视频

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

相关实验视频

Last Updated: Jun 21, 2026

Left Atrial Ligation in the Avian Embryo as a Model for Altered Hemodynamic Loading During Early Vascular Development
04:37

Left Atrial Ligation in the Avian Embryo as a Model for Altered Hemodynamic Loading During Early Vascular Development

Published on: June 16, 2023

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

结论:

  • 在HLHS的手术和重症监护管理方面取得了重大进展,改善了患者的预后.
  • 尽管取得了进展,但在HLHS幸存者的长期护理中,当他们过渡到成年时,他们面临着持续的挑战.
  • 持续创新手术技术和综合护理对于优化HLHS患者的治疗结果至关重要.